[[abstract]]BACKGROUND: Clinical trials provide information for developing new treatment strategies, enhancing cancer knowledge, and improving trial effectiveness. However, factors related to patients' participation in clinical trials have not been explored in Taiwan. OBJECTIVES: This study explored cancer patients' willingness to participate in clinical trials and motivational factors, barriers, needs, expectations, and other factors influencing their decision making. METHODS: In this cross-sectional study, information was collected using structured questionnaires with cancer patients from an academic medical center. RESULTS: Among 184 cancer patients sampled, most (87.5%) were willing to participate in a clinical trial. Their attitude tow...
Background: Patients invited to take part in a clinical trial may evoke an archetype on which they m...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Background: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatmen...
[[abstract]]BACKGROUND: Clinical trials provide information for developing new treatment strategies,...
The overall aim of this thesis was to study participants' understanding of clinical cancer trials, a...
Introduction: Prospective clinical trials are essential to translate new therapy concepts or rather ...
Successful advances in the treatment of advanced malignant diseases rely on recruitment of patients ...
Purpose The purpose of this study was to assess current levels of awareness of clinical trials (CTs)...
Abstract Background In the past few years, the number of clinical trials has increased rapidly in Ea...
Abstract Background: Communication with patients contemplating Phase 1 cancer trial participation ...
BACKGROUND: Communication with patients contemplating Phase 1 cancer trial participation can be chal...
BACKGROUND: Clinical cancer trials are crucial for the implementation of new treatments in the clini...
Background:Barriers to randomised clinical trial (RCT) recruitment include failure to identify eligi...
BACKGROUND: barriers to randomised clinical trial (RCT) recruitment include failure to identify elig...
Advances in cancer treatment are impeded by low accrual rates of patients to cancer clinical trials ...
Background: Patients invited to take part in a clinical trial may evoke an archetype on which they m...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Background: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatmen...
[[abstract]]BACKGROUND: Clinical trials provide information for developing new treatment strategies,...
The overall aim of this thesis was to study participants' understanding of clinical cancer trials, a...
Introduction: Prospective clinical trials are essential to translate new therapy concepts or rather ...
Successful advances in the treatment of advanced malignant diseases rely on recruitment of patients ...
Purpose The purpose of this study was to assess current levels of awareness of clinical trials (CTs)...
Abstract Background In the past few years, the number of clinical trials has increased rapidly in Ea...
Abstract Background: Communication with patients contemplating Phase 1 cancer trial participation ...
BACKGROUND: Communication with patients contemplating Phase 1 cancer trial participation can be chal...
BACKGROUND: Clinical cancer trials are crucial for the implementation of new treatments in the clini...
Background:Barriers to randomised clinical trial (RCT) recruitment include failure to identify eligi...
BACKGROUND: barriers to randomised clinical trial (RCT) recruitment include failure to identify elig...
Advances in cancer treatment are impeded by low accrual rates of patients to cancer clinical trials ...
Background: Patients invited to take part in a clinical trial may evoke an archetype on which they m...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Background: Recruitment of patients into randomised clinical trials (RCTs) is essential for treatmen...